Investment
Features
FeesSafety
Academy
More
Pluang+

Compare FuelCell Energy Inc (FCEL) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

FuelCell Energy IncTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

FuelCell Energy Inc vs Health Care Select Sector SPDR Fund — how do they compare? FuelCell Energy Inc trades at $16.97 (market cap $1.47B), while Health Care Select Sector SPDR Fund trades at $169.65 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 29.6× FuelCell Energy Inc's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, FuelCell Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold FuelCell Energy Inc for 48 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

FCELXLV
Market Cap
$1.47B$43.48B
Volume
12,559,94811,121,431
Sector
Industrials—
52-Week High
$36.01$175.68
52-Week Low
$6.00$141.95
Typical Hold Time
48 Days100 Days
Enterprise Value
$1.05B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

FuelCell Energy Inc

FuelCell Energy (FCEL) trades at $18.365, down 11.07% over 24 hours, with a bullish technical signal from moving averages but neutral oscillators. The company reported revenue of $158.16M in 2025 but posted a net loss of $187.90M, with negative gross and net income margins. Recent news highlights a securities class action lawsuit filed against the company, alleging misleading disclosures between June and September 2026.

FCEL faces significant financial challenges with persistent losses and negative cash flow from operations, though analyst consensus suggests a $21.57 price target with 40% buy ratings. Investment opportunities exist if the company achieves profitability, but risks include ongoing litigation, execution risks in scaling operations, and competitive pressures in the clean energy sector.

Health Care Select Sector SPDR Fund

XLV trades at $168.81, up 1.03% today, with a bullish technical signal driven by moving averages. The ETF holds 61 healthcare stocks from the S&P 500, offering broad sector exposure at a low 0.08% expense ratio. Recent news highlights its defensive appeal amid market volatility and potential Fed rate hikes, with articles comparing it favorably to peers like IBB and PJP on cost and diversification.

Outlook is positive given healthcare's defensive growth profile and XLV's cost efficiency, but risks include political uncertainty from midterm elections and sector-specific volatility from drug trial outcomes. Wall Street sentiment is constructive, with the ETF near key resistance at $170.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FCEL
61% Buy39% Sell
Avg holding period · 48 Days
XLV
53% Buy47% Sell
Avg holding period · 100 Days

Top news

Latest headlines on both assets

About FuelCell Energy Inc

FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.

Read more on FCEL →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →